Blood Biomarkers as Prognostic Indicators for Neurological Injury in COVID-19 Patients: A Systematic Review and Meta-Analysis

Z Huang, K Haile, L Gedefaw, BWM Lau, L Jin… - International Journal of …, 2023 - mdpi.com
Coronavirus disease 2019 (COVID-19) has been linked to various neurological
complications. This meta-analysis assessed the relationship between glial fibrillary acidic …

Plasma UCHL1, GFAP, tau, and NfL are not different in young healthy persons with mild COVID-19 symptoms early in the pandemic: a pilot study

MJ Rogatzki, RE Szeghy, NL Stute… - Neurotrauma …, 2023 - liebertpub.com
Elevated levels of brain injury biomarkers have been found primarily in middle-aged or older
persons experiencing moderate-to-severe COVID-19 symptoms. However, there is little …

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury

M Taquet, Z Skorniewska, H Zetterberg… - Brain …, 2024 - academic.oup.com
A proportion of patients infected with severe acute respiratory syndrome coronavirus 2
experience a range of neuropsychiatric symptoms months after infection, including cognitive …

Prevalence of long COVID symptoms in Haryana, India: a cross-sectional follow-up study

D Chaudhry, S Khandelwal, C Bahadur… - The Lancet Regional …, 2024 - thelancet.com
Background Emerging research indicates growing concern over long COVID globally,
although there have been limited studies that estimate population burden. We aimed to …

[HTML][HTML] Serum inflammatory and brain injury biomarkers in COVID-19 patients admitted to intensive care unit: a pilot study

S Kokkoris, E Stamataki, G Emmanouil, C Psachoulia… - ENeurologicalSci, 2022 - Elsevier
Background The aim of this study was to measure serum brain injury biomarkers in patients
with COVID-19 admitted to intensive care unit (ICU), without evidence of brain impairment …